Evaluating the Rationality of the International Guideline's Recommendations Regarding Selective Coverage of Level Ib in Node Clinical Target Volume With Nasopharyngeal Carcinoma: Results From a Real-World Series

医学 鼻咽癌 指南 鼻腔 放射治疗 入射(几何) 内科学 肿瘤科 放射科 外科 病理 光学 物理
作者
Qiaojuan Guo,Nan Xiao,Hua-shan Xu,Jingfeng Zong,Youping Xiao,Tianzhu Lu,Yun Xu,Bing Chen,Chanchan Hu,Xuru Zhang,Jianji Pan,Shu-I Lin
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier]
卷期号:111 (3): e383-e384
标识
DOI:10.1016/j.ijrobp.2021.07.1123
摘要

Purpose/Objective(s)Although the International Guideline for the delineation of clinical target volume (CTV) in nasopharyngeal carcinoma (NPC) patients has provided practical reference for the elective coverage of level 1b, there are marked variations in practice among different institutions, and the rationality of the recommendations remained proven. The purpose of this study was to evaluate its rationality in real-world data and provide clinical evidence for the refinement of nodal CTV delineation in nasopharyngeal carcinoma (NPC).Materials/MethodsPatients with histologically-proven NPC who received definitive Intensity-modulated radiation therapy (IMRT) with or without chemotherapy at Dr. SJ Lin's attending group in our institution between June 2005 and December 2012 were candidates for this retrospectively study. Other main eligible criteria including the following five situations: 1) level Ib metastasis;2)involvement of the submandibular gland;3) involvement of structures that drain to level Ib as the first echelon site (the oral cavity, anterior half of nasal cavity involvement);4) involvement of level II LNs with extracapsular extension (ECE); 5) level II nodal involvement with maximum nodal axial diameter (MAD) greater than 2 cm. Survival outcomes focused on regional recurrence-free survival (RRFS) and incidence rate of Ib recurrence were analyzed.ResultsA total of 451 patients were finally included according to the above criteria. There were 27, 37, 6, 12, 285 and 414 cases be classified as level Ib metastasis, submandibular gland involvement, oral cavity involvement, anterior half of nasal cavity involvement, level II LNs involvement with ECE and level II nodal involvement with MAD greater than 2 cm, respectively. Among these 451 patients, 60 patients received level Ib-covering IMRT due to the first three principles of the International Guideline according to our attending group's protocol. Of note, patients who had Ib involvement would receive ultrasound guided puncture, only those who had positive pathological results would undergo Ib-covering IMRT in our attending group. For the remaining 391 patients who only fulfilled the last two criteria and/or Ib involvement with negative pathological results, they all received level Ib-sparing IMRT, reported 6-year RRFS was 94.3%. For the 22 patients who had regional recurrence at censorship, only 3 (3/391, 0.78%) were recorded as Ib recurrence.ConclusionLevel Ib-sparing IMRT should be safe and feasible for patients who only had involvement of level II LNs with ECE, and/or had a MAD of greater than 2 cm in level II LNs, and/or Ib involvement with negative pathological results. Further well-designed multi-center prospective trials should be conducted to confirm our results. Although the International Guideline for the delineation of clinical target volume (CTV) in nasopharyngeal carcinoma (NPC) patients has provided practical reference for the elective coverage of level 1b, there are marked variations in practice among different institutions, and the rationality of the recommendations remained proven. The purpose of this study was to evaluate its rationality in real-world data and provide clinical evidence for the refinement of nodal CTV delineation in nasopharyngeal carcinoma (NPC). Patients with histologically-proven NPC who received definitive Intensity-modulated radiation therapy (IMRT) with or without chemotherapy at Dr. SJ Lin's attending group in our institution between June 2005 and December 2012 were candidates for this retrospectively study. Other main eligible criteria including the following five situations: 1) level Ib metastasis;2)involvement of the submandibular gland;3) involvement of structures that drain to level Ib as the first echelon site (the oral cavity, anterior half of nasal cavity involvement);4) involvement of level II LNs with extracapsular extension (ECE); 5) level II nodal involvement with maximum nodal axial diameter (MAD) greater than 2 cm. Survival outcomes focused on regional recurrence-free survival (RRFS) and incidence rate of Ib recurrence were analyzed. A total of 451 patients were finally included according to the above criteria. There were 27, 37, 6, 12, 285 and 414 cases be classified as level Ib metastasis, submandibular gland involvement, oral cavity involvement, anterior half of nasal cavity involvement, level II LNs involvement with ECE and level II nodal involvement with MAD greater than 2 cm, respectively. Among these 451 patients, 60 patients received level Ib-covering IMRT due to the first three principles of the International Guideline according to our attending group's protocol. Of note, patients who had Ib involvement would receive ultrasound guided puncture, only those who had positive pathological results would undergo Ib-covering IMRT in our attending group. For the remaining 391 patients who only fulfilled the last two criteria and/or Ib involvement with negative pathological results, they all received level Ib-sparing IMRT, reported 6-year RRFS was 94.3%. For the 22 patients who had regional recurrence at censorship, only 3 (3/391, 0.78%) were recorded as Ib recurrence. Level Ib-sparing IMRT should be safe and feasible for patients who only had involvement of level II LNs with ECE, and/or had a MAD of greater than 2 cm in level II LNs, and/or Ib involvement with negative pathological results. Further well-designed multi-center prospective trials should be conducted to confirm our results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
清嘉完成签到,获得积分10
1秒前
李阳发布了新的文献求助10
1秒前
秋雅完成签到,获得积分10
1秒前
2秒前
都是发布了新的文献求助10
3秒前
5秒前
peng发布了新的文献求助10
5秒前
七七完成签到,获得积分10
6秒前
是问完成签到 ,获得积分10
7秒前
anling发布了新的文献求助10
7秒前
陶醉觅夏发布了新的文献求助30
7秒前
科目三应助yizhi猫采纳,获得10
8秒前
科研顺利完成签到 ,获得积分10
9秒前
LiNCHOR完成签到,获得积分10
9秒前
10秒前
elisa828完成签到,获得积分10
11秒前
anling完成签到,获得积分10
13秒前
师妹完成签到,获得积分10
14秒前
cc发布了新的文献求助10
14秒前
搞怪柔发布了新的文献求助10
15秒前
16秒前
16秒前
熏香澡牝完成签到,获得积分10
18秒前
19秒前
24秒前
苗苗完成签到,获得积分10
26秒前
红豆小猫完成签到,获得积分10
26秒前
28秒前
甘樂完成签到,获得积分10
29秒前
29秒前
29秒前
30秒前
方远锋完成签到,获得积分10
32秒前
小蘑菇应助gzy780819采纳,获得10
32秒前
香蕉子骞发布了新的文献求助10
33秒前
小洋甘完成签到,获得积分10
34秒前
34秒前
完美世界应助carbon-dots采纳,获得10
34秒前
Morningstar发布了新的文献求助10
35秒前
高分求助中
Sustainability in Tides Chemistry 2800
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3138860
求助须知:如何正确求助?哪些是违规求助? 2789795
关于积分的说明 7792655
捐赠科研通 2446147
什么是DOI,文献DOI怎么找? 1300890
科研通“疑难数据库(出版商)”最低求助积分说明 626066
版权声明 601079